Literature DB >> 14612153

Oligomer formation by Na+-Cl--coupled neurotransmitter transporters.

Harald H Sitte1, Michael Freissmuth.   

Abstract

Na+-Cl--dependent neurotransmitter transporters (or neurotransmitter:Na+ symporters, NSS) share many structural and functional features, e.g. a conserved topology of 12 transmembrane spanning alpha-helices, the capacity to operate in two directions and in an electrogenic manner. Biochemical and biophysical experiments indicate that these transporters interact in oligomeric quaternary structures. Fluorescence resonance energy transfer (FRET) microscopy has provided evidence for a constitutive physical interaction of NSS at the cell surface and throughout the biosynthetic pathway. Two interfaces for protein-protein interaction have been shown to be important in NSS; these comprise a glycophorin-like motif and a leucine heptad repeat. Upon mutational modification of the latter, surface targeting is considerably impaired without concomitant loss in uptake activity. This supports a role of oligomer formation in the passage of the quality control mechanisms of the endoplasmic reticulum and/or Golgi. In contrast, oligomerisation is dispensable for substrate binding and translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612153     DOI: 10.1016/j.ejphar.2003.08.072

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Turnover rate of the gamma-aminobutyric acid transporter GAT1.

Authors:  Albert L Gonzales; William Lee; Shelly R Spencer; Raymond A Oropeza; Jacqueline V Chapman; Jerry Y Ku; Sepehr Eskandari
Journal:  J Membr Biol       Date:  2007-11-09       Impact factor: 1.843

Review 2.  Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Am J Ther       Date:  2009 Jul-Aug       Impact factor: 2.688

3.  Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies.

Authors:  Vladimir M Korkhov; Laura Milan-Lobo; Benoît Zuber; Hesso Farhan; Johannes A Schmid; Michael Freissmuth; Harald H Sitte
Journal:  J Mol Biol       Date:  2008-03-04       Impact factor: 5.469

4.  Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinities.

Authors:  Juan Zhen; Tamara Antonio; Shu-Yuan Cheng; Solav Ali; Kymry T Jones; Maarten E A Reith
Journal:  J Neurochem       Date:  2015-01-26       Impact factor: 5.372

5.  Functional properties of dopamine transporter oligomers after copper linking.

Authors:  Juan Zhen; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-12-21       Impact factor: 5.372

6.  The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.

Authors:  Weimin Conrad Hong; Hideaki Yano; Takato Hiranita; Frederick T Chin; Christopher R McCurdy; Tsung-Ping Su; Susan G Amara; Jonathan L Katz
Journal:  J Biol Chem       Date:  2017-05-11       Impact factor: 5.157

7.  Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane.

Authors:  Andreas Anderluh; Enrico Klotzsch; Alexander W A F Reismann; Mario Brameshuber; Oliver Kudlacek; Amy Hauck Newman; Harald H Sitte; Gerhard J Schütz
Journal:  J Biol Chem       Date:  2014-01-06       Impact factor: 5.157

8.  Role of the conserved glutamine 291 in the rat gamma-aminobutyric acid transporter rGAT-1.

Authors:  S A Mari; A Soragna; M Castagna; M Santacroce; C Perego; E Bossi; A Peres; V F Sacchi
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

9.  Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity.

Authors:  B Chanrion; C Mannoury la Cour; F Bertaso; M Lerner-Natoli; M Freissmuth; M J Millan; J Bockaert; P Marin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

Review 10.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.